These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 4390333

  • 1. The effects of 1-[di(2-chloroethyl)amino-methyl]benzimidazole and related compounds on the growth of experimental tumours.
    Reddy VV, Sirsi M, Revankar GR, Siddappa S.
    J Pharm Pharmacol; 1969 Sep; 21(9):573-6. PubMed ID: 4390333
    [No Abstract] [Full Text] [Related]

  • 2. 2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256.
    Cobb LM, Connors TA, Elson LA, Khan AH, Mitchley BC, Ross WC, Whisson ME.
    Biochem Pharmacol; 1969 Jun; 18(6):1519-27. PubMed ID: 4307990
    [No Abstract] [Full Text] [Related]

  • 3. The cancerostatic effects of some isothiocyanates on nitrogen mustard-sensitive and -resistant lines of Yoshida sarcoma.
    Miko M, Ujházy V.
    Neoplasma; 1968 Jun; 15(4):357-63. PubMed ID: 5684461
    [No Abstract] [Full Text] [Related]

  • 4. Preparation of derivatives of nitrogen mustard having structure of alpha-amino acid amide.
    Sakurai Y, Matsui E.
    Chem Pharm Bull (Tokyo); 1965 May; 13(5):594-8. PubMed ID: 5867717
    [No Abstract] [Full Text] [Related]

  • 5. Anticancer screening of SAN-AB: an extract of marking nut, Semecarpus anacardium.
    Gothoskar SV, Ranadive KJ.
    Indian J Exp Biol; 1971 Jul; 9(3):372-5. PubMed ID: 5144337
    [No Abstract] [Full Text] [Related]

  • 6. N-Bis (beta-chloroethyl) amino acids and their effect upon the Yoshida sarcoma.
    IZUMI M.
    Pharm Bull; 1954 Sep; 2(3):275-9. PubMed ID: 13215055
    [No Abstract] [Full Text] [Related]

  • 7. N-Bis (beta-chloroethyl) amino acid N-oxides and their effect upon the Yoshida sarcoma.
    IZUMI M.
    Pharm Bull; 1954 Sep; 2(3):279-83. PubMed ID: 13215056
    [No Abstract] [Full Text] [Related]

  • 8. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
    Ujházy V.
    Neoplasma; 1969 Sep; 16(4):467-8. PubMed ID: 5344233
    [No Abstract] [Full Text] [Related]

  • 9. Biologically active components of cobra venom in relation to cancer research.
    Braganca BM.
    Indian J Med Res; 1976 Aug; 64(8):1197-207. PubMed ID: 992850
    [No Abstract] [Full Text] [Related]

  • 10. [On the problem of the effectiveness of d-glyceraldehyde].
    Brock N, Niekamp T.
    Z Krebsforsch; 1965 Jul 01; 67(1):93-104. PubMed ID: 4221137
    [No Abstract] [Full Text] [Related]

  • 11. [Experimental study and clinical application of the effect of Anadrol on cancer bearing organisms].
    Ichihashi H, Ookubo K, Kondo T.
    Saishin Igaku; 1966 Oct 01; 21(10):2312-6. PubMed ID: 5981324
    [No Abstract] [Full Text] [Related]

  • 12. [Selective effect of N,N-bis-(2-chloroethyl)-N1,O-propylenephosphoric acid ester-diamide and analogues on the CAM-tumor system].
    Rauen HM, Norpoth K, Sunder-Plassmann A.
    Arzneimittelforschung; 1968 Jan 01; 18(1):105-9. PubMed ID: 5754936
    [No Abstract] [Full Text] [Related]

  • 13. Host resistance against tumor and its synergic effect with cancer chemotherapy.
    Sato R.
    Gan; 1967 Jun 01; 58(3):211-20. PubMed ID: 6081225
    [No Abstract] [Full Text] [Related]

  • 14. [Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. VIII. Estimation of time during which nitrogen mustard derivatives remain effective in the peritoneal cavity].
    ISHIDATE M, SAKURAI Y, YOSHIDA T, SATOH H, IMAMURA H.
    Gan; 1955 Sep 01; 46(2-3):469-74. PubMed ID: 13262460
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitory activity of L-asparaginase from Mycobacterium tuberculosis on Yoshida ascites sarcoma in rats.
    Reddy VV, Jayaram HN, Sirsi M, Ramakrishnan T.
    Arch Biochem Biophys; 1969 Jun 01; 132(1):262-7. PubMed ID: 4978855
    [No Abstract] [Full Text] [Related]

  • 16. [On the inhibitory effect of nitrogen-mustard N-oxide (MBAO) upon subcutaneous solid tumors of the Yoshida sarcoma].
    KAZIWARA K.
    Gan; 1952 Sep 01; 43(2-3):328-40. PubMed ID: 12998884
    [No Abstract] [Full Text] [Related]

  • 17. A new substance effective against transplantable tumors in vivo: L-cystine-bis-(N,N-beta-chloroethyl)-hydrazide.
    Golovinsky EV, Alexiev BV, Spassov AV, Stoev SB, Emanuilov EA, Angelov II, Maneva LS, Stoychev TS.
    Neoplasma; 1977 Sep 01; 24(4):401-4. PubMed ID: 904741
    [Abstract] [Full Text] [Related]

  • 18. [Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. X. Inhibiting effects of various nitrogen mustards upon small number of Yoshida sarcoma cells].
    ISHIDATE M, SAKURAI Y, YOSHIDA T, SATOH H, IMAMURA H.
    Gan; 1955 Sep 01; 46(2-3):480-2. PubMed ID: 13262462
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R, Harrap KR.
    Br J Cancer; 1982 Mar 01; 45(3):413-20. PubMed ID: 7073935
    [Abstract] [Full Text] [Related]

  • 20. Antitumor and toxicologic effects of p-carboxycarbanilic acid, N-(p-(bis(2-chloroethyl)amino)phenyl) ester (NSC-130998; IC 140).
    Hebborn P, Simpson CL, Mihich E.
    Cancer Chemother Rep; 1970 Feb 01; 54(1):23-30. PubMed ID: 5538162
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.